FOR IN VITRO LABORATORY AND SCIENTIFIC RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, NOT FOR THERAPEUTIC USE, AND NOT A TGA-REGISTERED PRODUCT. THE INFORMATION BELOW IS PROVIDED SOLELY TO IDENTIFY THE COMPOUND FOR RESEARCH PURPOSES.
Overview
Retatrutide, also identified by its development code LY3437943, is a synthetic peptide that has been studied in the published scientific literature as a triple receptor agonist. It is supplied by Helyx Research Australia as a sterile, lyophilised powder in a sealed 10mg vial for in vitro laboratory research. This page provides reference information about the compound; it makes no health or therapeutic claim of any kind.
Molecular Reference Data
- Compound name: Retatrutide
- Research code: LY3437943
- CAS number: 2381272-17-7
- Molecular formula: C₄₅H₇₆N₁₈O₁₄ (synthetic peptide)
- Molecular weight: approximately 1,519.62 g/mol
- Appearance: white to off-white lyophilised powder
- Form supplied: 10mg per sealed vial, inert-gas sealed
- Purity: ≥99% by HPLC (current batch JP20260015 tested 99.103%)
Research Context
Retatrutide has been described in peer-reviewed pharmacology research as a peptide that interacts with multiple incretin-related receptor targets. As a research reference material, it is used in in vitro receptor-binding studies, analytical method development, and comparative peptide characterisation work. Researchers should consult the primary scientific literature for the experimental context relevant to their own study design. Helyx Research Australia does not provide research protocols, dosing, or any guidance on use in living systems.
Stability and Storage
As supplied, the sealed lyophilised vial is stable for approximately 24 months when stored at -20°C, protected from light. Lyophilised peptides are generally more stable than reconstituted solutions. To preserve integrity, vials should be moved to cold storage promptly on receipt and protected from repeated temperature cycling. Storage outside the stated conditions can affect the compound and invalidate the batch specification.
Quality Verification
Every batch is independently verified by third-party HPLC and mass spectrometry before sale. The full Certificate of Analysis for the current batch, including the testing laboratory's verification key, is published on the product page. View the current Certificate of Analysis.
Availability
Retatrutide 10mg research vials are held in Australian domestic stock and dispatched same day for orders paid before 12pm. Bulk pricing applies automatically from two vials. Order the Retatrutide 10mg research vial, or read more about Helyx Research Australia and our compliance position.